MECOM and acute myeloid leukemia: Similarly, transplant of naïve iKMT2A-MLLT3 LT-HSC in DOX-treated recipients induced in few recipients a particularly rapid and invasive Evi1+AML in a however unpredictable manner and it remained unclear whether the disease originated from LT-HSC or MPP19.